Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated?

BACKGROUND: Neoadjuvant chemotherapy (NACT) and oesophagectomy is the standard of care for resectable oesophageal adenocarcinomas. Survival outcomes following resection have been improving over time while NACT remain largely unchanged. Indeed, a recent meta-analysis of randomized control trials did...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jin-Soo, Van der Wall, Hans, Kennedy, Catherine, Falk, Gregory L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554721/
https://www.ncbi.nlm.nih.gov/pubmed/34754391
http://dx.doi.org/10.4240/wjgs.v13.i10.1235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554721/
https://www.ncbi.nlm.nih.gov/pubmed/34754391
http://dx.doi.org/10.4240/wjgs.v13.i10.1235

Ejemplares similares